查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
次世代定序服務市場規模、佔有率和成長分析（按類型、技術、工作流程、最終用途、應用和地區分類）—2026-2033年產業預測
市場調查報告書
商品編碼
1899132

次世代定序服務市場規模、佔有率和成長分析（按類型、技術、工作流程、最終用途、應用和地區分類）—2026-2033年產業預測

Next-Generation Sequencing Services Market Size, Share, and Growth Analysis, By Type (Human Genome Sequencing, Single Cell Sequencing), By Technology, By Workflow, By End Use, By Application, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球次世代定序服務市場規模預計在 2024 年達到 102.8 億美元，從 2025 年的 125.8 億美元成長到 2033 年的 634 億美元，在預測期（2026-2033 年）內複合年成長率為 22.4%。

由於次世代定序(NGS) 技術在生物技術、醫學診斷和病毒學等多個領域具有變革性影響，其全球市場正迅速擴張。這項先進的DNA測序技術能夠快速且有效率地解碼整個基因組，相比傳統的桑格定序等方法具有顯著優勢。 NGS 的擴充性和高通量能力使其成為全球臨床實驗室分析和疾病診斷的重要組成部分。該技術還有助於加速藥物基因組學領域的藥物發現進程，增強對早期檢測和個人化治療至關重要的生物標記的識別。因此，NGS 在分子生物學和遺傳學的發展以及從傳統診斷到精準醫療的轉變過程中發揮關鍵作用。

推動全球次世代定序服務市場發展的因素

在臨床診斷技術不斷進步的推動下，全球次世代定序（NGS）服務市場正經歷顯著成長。 NGS技術在法醫學、生殖醫學、個人化醫療、生物標記和診斷等領域的廣泛應用，凸顯了其多功能性和重要性。 NGS技術憑藉其分析準確性、高通量能力和成本效益，已成為臨床檢查室診斷遺傳疾病的首選技術。這項創新技術不僅能夠實現精準診斷，還能透過基因測序為罕見疾病管理提供有效途徑。在此背景下，市場對NGS服務的需求持續成長，推動市場擴張和技術在多個領域的整合。

全球次世代定序服務市場面臨的限制因素

全球次世代定序服務市場面臨著與DNA定序固有的法律和倫理考量相關的許多挑戰。這些複雜問題包括文化敏感度、可識別性問題、研究結果共用的影響、潛在的刻板印象、知情同意的充分性、污名化風險、整體性問題以及不同群體利益分配不均等。這些倫理困境對市場成長構成重大障礙，因為相關人員必須謹慎行事，因為在這種環境下，負責任且公平地使用定序技術所帶來的影響和後果將受到嚴格審查。解決這些問題對於促進市場的未來發展至關重要。

次世代定序服務市場的全球趨勢

全球次世代定序服務市場正見證著第三代定序技術的顯著應用趨勢，這些技術正在革新基因組分析中。以單分子定序方法為特徵的這些進步，無需克隆擴增和聚合酵素鏈鎖反應(PCR)，從而減少了傳統方法中常見的誤差。因此，利用單分子即時 (SMRT)定序、FRET定序和奈米孔定序的平台因其能夠提供更長的讀長並簡化製備流程而備受關注。這一發展不僅提高了定序的準確性，而且使其能夠在包括醫學研究、診斷和個人化醫療在內的廣泛領域中得到應用，從而推動了該領域的蓬勃發展。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2025）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球次世代定序服務市場規模（按類型和複合年成長率分類）（2026-2033 年）

  • 人類基因組定序
  • 單細胞定序
  • 微生物基因組定序
  • 基因調控服務
    • 小RNA定序
    • 晶片定序
    • 其他基於基因調控的服務
  • 動植物定序
  • 其他定序服務

全球次世代定序服務市場規模（依技術及複合年成長率分類）（2026-2033 年）

  • 合成定定序
  • 離子半導體定序
  • 奈米孔定序
  • 單分子即時定序
  • 其他技術

全球次世代定序服務市場規模（按工作流程和複合年成長率分類）（2026-2033 年）

  • 定序預處理
  • 定序
  • 數據分析

全球次世代定序服務市場規模（依最終用途分類）及複合年成長率（2026-2033 年）

  • 大學和其他研究機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

全球次世代定序服務市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

  • 診斷
  • 腫瘤學
  • 生殖醫學
  • 感染疾病
  • 罕見遺傳疾病
  • 其他
  • 藥物發現
  • 生物標記發現
  • 微生物遺傳學、農業和動物研究
  • 其他用途

全球次世代定序服務市場規模及複合年成長率（2026-2033）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2025 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Illumina, Inc.（USA）
  • Thermo Fisher Scientific Inc.（USA）
  • BGI Genomics Co., Ltd.（China）
  • Eurofins Scientific SE（Luxembourg）
  • QIAGEN NV（Netherlands）
  • Agilent Technologies, Inc.（USA）
  • PerkinElmer, Inc.（USA）
  • Macrogen, Inc.（South Korea）
  • Pacific Biosciences of California, Inc.（USA）
  • Oxford Nanopore Technologies plc（UK）
  • Novogene Co., Ltd.（China）
  • Psomagen, Inc.（USA）
  • 10x Genomics, Inc.（USA）
  • Takara Bio Inc.（Japan）
  • Zymo Research Corp.（USA）
  • CD Genomics（USA）
  • MedGenome Labs Pvt Ltd.（India）
  • Fulgent Genetics, Inc.（USA）
  • Personalis, Inc.（USA）

結論與建議

簡介目錄
Product Code: SQSG35A2092

Global Next-Generation Sequencing Services Market size was valued at USD 10.28 Billion in 2024 and is poised to grow from USD 12.58 Billion in 2025 to USD 63.4 Billion by 2033, growing at a CAGR of 22.4% during the forecast period (2026-2033).

The global market for next-generation sequencing (NGS) services is witnessing rapid expansion due to its transformative impact across various fields such as biotechnology, medical diagnostics, and virology. This advanced DNA sequencing technology enables the rapid and efficient sequencing of entire genomes, providing significant advantages over traditional methods like Sanger sequencing. Its scalability and high throughput capabilities make NGS essential in clinical laboratory analysis and disease diagnosis worldwide. The technology also facilitates accelerated drug discovery processes in pharmacogenomics and enhances the identification of biomarkers critical for early detection and individualized therapies. As a result, NGS plays a pivotal role in advancing molecular biology, genetics, and the evolution from conventional diagnosis to a precision medicine approach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segments Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is experiencing significant growth fueled by ongoing advancements in clinical diagnostics. Various applications, including forensics, reproductive health, personalized medicine, biomarkers, and diagnostics, highlight the versatility and importance of NGS technology. Its analytical precision, high throughput capabilities, and cost-efficiency have established NGS as the preferred choice in clinical laboratories for diagnosing genetic disorders. This innovation not only facilitates accurate diagnoses but also presents a viable approach to managing rare diseases through genomic sequencing. As such, the demand for NGS services continues to rise, propelling market expansion and technological integration across numerous sectors.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market faces various challenges related to legal and ethical considerations inherent in DNA sequencing. These complex issues encompass cultural sensitivities, concerns about identifiability, the impact of sharing study results, potential stereotyping, the adequacy of informed consent, risk of stigmatization, matters of inclusion, and the unequal benefits to different groups. Together, these moral dilemmas create significant barriers to market growth, as stakeholders must navigate a landscape filled with scrutiny over the implications and consequences of utilizing sequencing technologies responsibly and equitably. Addressing these concerns is crucial for fostering the future development of the market.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market is experiencing a notable trend towards the adoption of third-generation sequencing technologies, which are revolutionizing genomic analysis. These advancements, characterized by single-molecule sequencing approaches, eliminate the need for clonal amplification and polymerase chain reaction (PCR), thereby reducing errors associated with these traditional methods. As a result, platforms utilizing Single-Molecule Real-Time (SMRT) sequencing, FRET sequencing, and Nanopore sequencing are gaining traction due to their ability to deliver longer read lengths and simplify preparatory workflows. This evolution not only enhances the accuracy of sequencing but also broadens applications across medical research, diagnostics, and personalized medicine, driving significant growth in the sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Human Genome Sequencing
  • Single Cell Sequencing
  • Microbial Genome-Based Sequencing
  • Gene Regulation Services
    • Small RNA Sequencing
    • Chip Sequencing
    • Other Gene Regulation-Based Services
  • Animal & Plant Sequencing
  • Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2026-2033)

  • Market Overview
  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Diagnostics
  • Oncology
  • Reproductive Health
  • Infectious Diseases
  • Rare Genetic Disorders
  • Others
  • Drug Discovery
  • Biomarker Discovery
  • Microbial Genetics, Agriculture, And Animal Research
  • Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2026-2033)

  • North America (Type, Technology, Workflow, End Use, Application)
    • US
    • Canada
  • Europe (Type, Technology, Workflow, End Use, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Workflow, End Use, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Workflow, End Use, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Workflow, End Use, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Genomics Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macrogen, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corp. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CD Genomics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedGenome Labs Pvt Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fulgent Genetics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Personalis, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations